These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29414635)

  • 1. A new approach to estimate time-to-cure from cancer registries data.
    Boussari O; Romain G; Remontet L; Bossard N; Mounier M; Bouvier AM; Binquet C; Colonna M; Jooste V
    Cancer Epidemiol; 2018 Apr; 53():72-80. PubMed ID: 29414635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-to-cure and cure proportion in solid cancers in France. A population based study.
    Romain G; Boussari O; Bossard N; Remontet L; Bouvier AM; Mounier M; Iwaz J; Colonna M; Jooste V;
    Cancer Epidemiol; 2019 Jun; 60():93-101. PubMed ID: 30933890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
    Stedman MR; Feuer EJ; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
    Dal Maso L; Toffolutti F; De Paoli A; Giudici F; Francisci S; Bucchi L; Zorzi M; Fusco M; Caldarella A; Rossi S; De Angelis R; Botta L; Ravaioli A; Casella C; Musolino A; Vitale MF; Mangone L; Fanetti AC; Carpin E; Burgio Lo Monaco MG; Migliore E; Gambino ML; Ferrante M; Stracci F; Gasparotti C; Carrozzi G; Cavallo R; Mazzucco W; Ballotari P; Ferretti S; Sampietro G; Rizzello RV; Boschetti L; Cascone G; Mian M; Pesce MT; Piras D; Galasso R; Bella F; Seghini P; Pinna P; Crocetti E; Serraino D; Guzzinati S;
    Int J Cancer; 2024 Jul; 155(2):270-281. PubMed ID: 38520231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
    Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
    Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
    Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
    Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
    Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
    Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the proportion cured of cancer: some practical advice for users.
    Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
    Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.
    Azizmohammad Looha M; Pourhoseingholi MA; Nasserinejad M; Najafimehr H; Zali MR
    Epidemiol Health; 2018; 40():e2018045. PubMed ID: 30220192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of cancer for seven cancer sites in the Flemish Region.
    Silversmit G; Jegou D; Vaes E; Van Hoof E; Goetghebeur E; Van Eycken L
    Int J Cancer; 2017 Mar; 140(5):1102-1110. PubMed ID: 27870056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Report of Cancer Incidence and Mortality in China, 2014].
    Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
    [No Abstract]   [Full Text] [Related]  

  • 15. Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
    Toffolutti F; Guzzinati S; De Paoli A; Francisci S; De Angelis R; Crocetti E; Botta L; Rossi S; Mallone S; Zorzi M; Manneschi G; Bidoli E; Ravaioli A; Cuccaro F; Migliore E; Puppo A; Ferrante M; Gasparotti C; Gambino M; Carrozzi G; Stracci F; Michiara M; Cavallo R; Mazzucco W; Fusco M; Ballotari P; Sampietro G; Ferretti S; Mangone L; Rizzello RV; Mian M; Cascone G; Boschetti L; Galasso R; Piras D; Pesce MT; Bella F; Seghini P; Fanetti AC; Pinna P; Serraino D; Dal Maso L;
    Front Oncol; 2023; 13():1168325. PubMed ID: 37346072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data.
    Botta L; Goungounga J; Capocaccia R; Romain G; Colonna M; Gatta G; Boussari O; Jooste V
    BMC Med Res Methodol; 2023 Mar; 23(1):70. PubMed ID: 36966273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The shape of the hazard function in breast carcinoma: curability of the disease revisited.
    Yakovlev AY; Tsodikov AD; Boucher K; Kerber R
    Cancer; 1999 Apr; 85(8):1789-98. PubMed ID: 10223574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
    Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects.
    Baade PD; Youlden DR; Chambers SK
    Med J Aust; 2011 Jan; 194(2):73-7. PubMed ID: 21241220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major patterns of cancer cure: Clinical implications.
    Tralongo P; Surbone A; Serraino D; Dal Maso L
    Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13139. PubMed ID: 31436897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.